Investor Presentation • Dec 1, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
December 2025


This presentation and the information contained herein (together, the "Presentation") are strictly confidential and are provided to you on the condition that you agree to hold it in strict confidence and not photocopy, disseminate, reproduce, disclose, divulge, forward, or distribute them directly or indirectly in whole or in part, by any medium or in any form to any other person or entity without the prior written consent of Meitav Investment House Ltd. (the "Company"), except to the recipient's officers, directors, employees, and agents for use in connection with such evaluation, as required by applicable law or regulation, as requested by regulatory authorities, or with the consent of the Company, provided, however, that the foregoing restrictions shall not apply to information that is or becomes generally available to the public (other than as a result of a disclosure in violation of such foregoing restrictions) or that is or becomes available to the recipient on a non-confidential basis from a source other than the Company that, to the recipient's knowledge (after reasonable inquiry), is not prohibited from disclosing the information to the recipient. This Presentation is intended for the recipient hereof and is for informational purposes only. By accepting this Presentation, each recipient expressly agrees to treat this Presentation and the information contained herein or accompanying it in a confidential manner and in accordance with its compliance policies, contractual obligations, and applicable law, including federal and state securities laws and the Israeli Securities Law of 1968 (the "Israeli Securities Law"). Upon request, the recipient agrees to promptly return all materials received from the Company (including this Presentation) without retaining any copies thereof. Each recipient further agrees that the foregoing obligations shall apply to all other written or oral communications transmitted to the recipient by or on behalf of the Company. You shall ensure that any person to whom you disclose any of this information complies with this paragraph.
The securities offered pursuant to the preliminary offering memorandum have not been registered under the Securities Act or any state securities laws, and may not be offered or sold within the United States, or to or for the account or benefit of U.S. persons, unless an exemption from the registration requirements of the Securities Act is available or they are otherwise sold pursuant to an effective registration statement filed with the Securities and Exchange Commission. This Presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offer or sale of such securities will only be made (i) within the United States, or to or for the account or benefit of U.S. persons, only to qualified institutional buyers ("QIBs") and (ii) outside the United States in offshore transactions in accordance with Regulation S, and in the case of each of (i) and (ii) above, outside of Israel to investors who are either (1) entities with equity exceeding NIS 50,000,000 or an equivalent amount in another currency, based on the latest financial statements; or (2) entities that together with any entity controlling, controlled or under common control with such entity, in the aggregate, (y) have assets under management in an aggregate amount exceeding NIS 100,000,000 or an equivalent amount in another currency provided that the Shares purchased in the Offering would be purchased for the assets under management; and/or (z) own and invest on a discretionary basis in securities of issuers that are not affiliated with such entity, in an aggregate amount exceeding NIS 100,000,000 or an equivalent amount in another currency. Inside of Israel, the securities may be offered and sold to certain Israeli "institutional investors" (as such term is defined in Section 1 of the Securities Regulations (The Manner of Offering Securities to the Public), 5767-2007 promulgated under the Israeli Securities Law. Any purchaser of such securities in the United States, or to or for the account of U.S. persons, will be deemed to have made certain representations and acknowledgments, including, without limitation, that the purchaser is a QIB. The Company has prepared a preliminary offering memorandum for the proposed offering to which the information in this Presentation relates. Before you invest, you should read the detailed information in that preliminary offering memorandum for more complete information about the Company and the offering. This Presentation is intended for the recipient hereof and is for informational purposes only. By accepting this Presentation, each recipient expressly agrees to treat this Presentation and the information contained herein or accompanying it in a confidential manner and each recipient shall ensure that any person to whom it discloses any of this information complies with this paragraph. The preliminary offering memorandum modifies and supersedes in its entirety any information in this Presentation or which has otherwise been previously provided. You should rely solely on the information contained in the preliminary offering memorandum to make an investment decision.
The information and opinions contained in this Presentation (including forward-looking statements) are made as of the date identified on the cover page of this Presentation unless otherwise stated herein. They are subject to change without notice and neither the Company nor any other person is under any obligation to update or keep current the information contained in this document and neither the Company nor any other person intends to update or otherwise revise such information or opinions (including any forward-looking statements) to reflect the occurrence of future events or developments even if any of the assumptions, judgments, and estimates on which the information contained herein is based prove to be incorrect, made in error, or become outdated. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness, or correctness of the information or opinions contained herein, and any reliance you place on them will be at your sole risk. The Company, its affiliates, and advisors do not accept any liability whatsoever for any loss howsoever arising, directly or indirectly, from the use of this document or its contents, or otherwise arising in connection with this document.
This Presentation does not constitute or form part of, and should not be construed as, an offer to sell or issue or the solicitation of an offer to buy or acquire securities of the Company, nor shall there be any sale of securities in any state or other jurisdiction to any person or entity to which it is unlawful to make such offer, solicitation, or sale in such state or jurisdiction.
This Presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Israeli Securities Law. All statements contained in this Presentation that do not relate to matters of historical fact should be considered forwardlooking statements, including statements relating to: customer rentention; governmental regulations and approvals; general market, political and economic conditions in Israel, including the duration and scope of any reescalation of war in Israel and conflicts in the Middle East, and the potential impact on the Company's operations; cybersecurity risks; changes in macro-economic conditions; differences in anticipated and actual fund performance; changes in the competitive environment; and the outcome of legal and/or regulatory proceedings. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential," or "continue" or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements are identified by these terms or expressions. In addition, statements that "we believe" and similar statements reflect management's beliefs and opinions on the relevant subject. These statements are based upon information available to management as of the date of this presentation, and while management believes such information forms a reasonable basis for such statements, such information may be limited or incomplete, and such statements should not be read to indicate that management has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
Management has based these forward-looking statements largely on their current expectations and projections about future events and financial trends that management believes may affect the Company's business, financial condition, and results of operations. The Company may not actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements, including but not limited to, the risk factors set forth in the preliminary offering memorandum and the documents incorporated by reference therein.
In light of these assumptions, risks, and uncertainties, the results and events discussed in the forward-looking statements contained in this Presentation by reference might not occur. You should review this Presentation completely and with the understanding that the Company's actual future results may be materially different from what management expects and should not place undue reliance on the forward-looking statements, which speak only as of the date of this Presentation. Except as required by applicable law, the Company does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances, or otherwise.
Market data and industry information used throughout this Presentation are based on management's knowledge of the industry and the good faith estimates of management. Management also relied, to the extent available, upon management's review of independent industry surveys and publications and other publicly available information prepared by a number of third-party sources. All of the market data and industry information used in this Presentation involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. Although we believe that these sources are reliable, we cannot guarantee the accuracy or completeness of this information, and we have not independently verified this information. While we believe the estimated market position, market opportunity, and market size information included in this Presentation are generally reliable, such information, which is derived in part from management's estimates and beliefs, is inherently uncertain and imprecise. No representations or warranties are made by the Company or any of its affiliates as to the accuracy of any such statements or projections. Projections, assumptions, and estimates of our future performance and the future performance of the industry in which we operate are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described above. These and other factors could cause results to differ materially from those expressed in our estimates and beliefs and in the estimates prepared by independent parties.




Note: As at 30/09/2025
2) AUM Assets Under Management
3) For definition of Adj. EBITDA, see Page 4 of the Board of Director's report for Q3 2025
• Total group revenue: NIS 515 million, reflecting 25% increase compared to the same quarter last year.




Note: 30/09/2025 % of BoP AUM figures are annualized



Note: As at 30/09/2025 6



36%
• Adjusted EBITDA of NIS 219 million in the current quarter, an increase of approximately 45% compared to the same quarter last year, an annual rate of NIS 876 million






1) Note: As at 30/09/2025
2) Please see cautionary language and disclaimer regarding forward-looking statements in slide 2 of this Investors Presentation







• The class-action settlement was approved in August 2025, and a process of more than a decade was completed. The Company cancelled a provision of NIS 375 million in Q3



1) Segment profit excluding effect of legal claims
AUM
191 NIS Billion




Note: As at 30/09/2025
AUM Portfolio Management
90 NIS Billion
Actively Managed Mutual Funds
ETFs & Tracking Funds







Real Estatebacked credit for private clients in Israel
Meitav: Financing

SME Real Estate First Lien Credit in Ireland
Lotus Investment Group (1)
Property & Construction Finance

Note: As at 30/09/2025
1) Lotus – Including Emerald Credit Funds





Real Estatebacked credit for private clients in Israel

SME Real Estate First Lien Credit in Ireland

Note: As at 30/09/2025 18




Note: As at 30/09/2025
39 NIS Billion
approximately
112,000


| As of 30.09.2025 |
As of 31.12.2024 |
|
|---|---|---|
| Cash and short-term investments | 571 | 529 |
| Other current assets | 2,581 | 2,220 |
| Total current assets | 3,152 | 2,749 |
| Long term investments | 1,367 | 1,127 |
| Fixed assets and intangible assets | 1,607 | 1,522 |
| Deferred taxes | 54 | 79 |
| Total assets | 6,180 | 5,477 |
| Net Debt to EBITDA(1) | Net Debt (1) |
|
|---|---|---|
| 0.47 | 332 |
| As of 30.09.2025 |
As of 31.12.2024 |
|
|---|---|---|
| Credit from banks and others | 2,161 | 1,910 |
| Liabilities for short sale of securities | 116 | 91 |
| Trade and other payables | 529 | 439 |
| Liabilities for legal claims | 143 | 676 |
| Total current liabilities | 2,949 | 3,116 |
| Debentures | 679 | 477 |
| Other long term liabilities | 943 | 767 |
| Equity | 1,427 | 848 |
| Non-controlling interests | 182 | 269 |
| Total liabilities and equity | 6,180 | 5,477 |

| 9M 2025 |
Q3 2025 |
Q2 2025 |
Q3 2024 |
2024 | |
|---|---|---|---|---|---|
| Revenue from management fees, commissions and other | 1,155 | 416 | 379 | 332 | 1,301 |
| Income from non-bank credit activity | 288 | 99 | 98 | 81 | 318 |
| Total revenue | 1,443 | 515 | 477 | 413 | 1,619 |
| Income refund in respect of legal claims against the Company | 203 | 203 | - | - | (2) |
| Total revenue | 1,646 | 718 | 477 | 413 | 1,617 |
| Marketing, operation, general and administrative expenses | 832 | 288 | 275 | 249 | 1,004 |
| Financing expenses for non-bank credit | 119 | 43 | 38 | 36 | 134 |
| Operating income | 695 | 387 | 164 | 128 | 479 |
| Profit from securities held for nostro portfolio investments, net | 17 | 6 | 6 | 2 | 12 |
| Financing income (expenses), net | 191 | 225 | (22) | (22) | (65) |
| Other income (expenses), net | (7) | (3) | 1 | (3) | (6) |
| Company's share in profits (losses) in equity accounted investees, net | 1 | 1 | - | (2) | (27) |
| Profit before taxes on income | 897 | 616 | 149 | 103 | 393 |
| Taxes on income | 136 | 64 | 41 | 32 | 103 |
| Profit for the period | 761 | 552 | 108 | 71 | 290 |
| Profit attributed to the Shareholders | 727 | 542 | 95 | 62 | 256 |

| 9M 2025 |
Q3 2025 |
Q2 2025 |
Q3 2024 |
2024 | |
|---|---|---|---|---|---|
| Revenue from management fees, commissions and other | 1,155 | 416 | 379 | 332 | 1,301 |
| Income from non-bank credit activity | 288 | 99 | 98 | 81 | 318 |
| Total revenue | 1,443 | 515 | 477 | 413 | 1,619 |
| Marketing, operation, general and administrative expenses | 832 | 288 | 275 | 249 | 999 |
| Financing expenses for non-bank credit | 119 | 43 | 38 | 36 | 134 |
| Operating income | 492 | 184 | 164 | 128 | 486 |
| Profit from securities held for nostro portfolio investments, net | 17 | 6 | 6 | 2 | 12 |
| Financing expenses, net | (26) | (11) | (9) | (10) | (33) |
| Other income (expenses), net | (7) | (3) | 1 | (3) | (6) |
| Company's share in profits (losses) in equity accounted investees, net | 1 | 1 | - | (2) | (27) |
| Profit before taxes on income | 477 | 177 | 162 | 115 | 432 |
| Taxes on income | 124 | 52 | 41 | 32 | 103 |
| Profit for the period | 353 | 125 | 121 | 83 | 329 |
| Profit attributed to the Shareholders | 319 | 115 | 108 | 74 | 295 |




Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.